Company research / TENX

TENAX THERAPEUTICS, INC. (TENX)

Build a valuation ↗↓ Download CSV

CIK 0000034956 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, TENAX THERAPEUTICS, INC. reported revenue of $0.

Key ratios (year ended 2025-12-31)

-54.2%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$0	$0	—	—	—	—	—	—	—	—
Cost of Revenue	—	—	—	—	—	—	—	—	—	$0
Gross Profit	—	—	—	—	—	—	—	—	—	$0
Operating Income	-$56.38M	-$19.49M	-$8.23M	$11.05M	-$32.73M	$9.87M	-$8.56M	-$6.89M	-$9.21M	-$52.65M
Net Income	-$52.60M	-$17.60M	-$7.71M	$11.05M	-$32.47M	-$9.85M	-$8.39M	-$14.14M	-$8.84M	-$43.92M
EPS (Diluted)	$-1.34	$-1.15	$-31.04	—	—	—	—	—	—	—
Total Assets	$104.23M	$96.69M	$11.69M	$3.40M	$5.99M	$6.87M	$6.37M	$13.34M	$9.89M	$23.34M
Total Liabilities	$7.16M	$4.69M	$3.59M	$1.91M	$1.75M	$2.24M	$2.59M	$1.57M	$1.01M	$6.20M
Shareholders' Equity	$97.07M	$91.99M	$8.10M	$1.49M	$4.24M	$4.63M	$3.77M	$11.77M	$8.88M	$17.14M
Cash & Equivalents	$97.60M	$94.90M	$9.80M	$2.12M	$5.58M	$6.25M	$4.91M	$12.37M	$1.60M	$10.00M
Operating Cash Flow	-$35.80M	-$14.81M	-$5.90M	-$11.39M	-$10.86M	-$9.27M	-$7.56M	-$5.50M	-$12.14M	-$15.87M
Capital Expenditures	—	—	—	$2.3K	$5.3K	$3.5K	$3.6K	$7.6K	$4.5K	$2.9K
Shares Outstanding	9.31M	3.42M	298.3K	28.6K	1.26M	12.62M	6.74M	3.79M	1.41M	1.41M
Weighted Average Diluted Shares	39.22M	15.27M	248.4K	—	—	—	—	—	—	—
EPS (Basic)	$-1.34	$-1.15	$-31.04	—	—	—	—	—	—	—